Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...] …
Articles by : Rich Daly, Editor in Chief
Mississippi this week became the fourth state to face a legal challenge to its 340B contract pharmacy law, when the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maryland this week became the third state with a 340B contract pharmacy protection law to face a drugmaker lawsuit when [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A fellow from a think tank that receives drug industry funding for its 340B work and a national leader for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Congress’ in-house non-partisan research arm recently produced a summary of the range of policy actions affecting 340B contract pharmacy use [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators said they were dropping from consideration a proposal for “stacking” discounts as part of an update to Medicaid [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...] …